Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study.

MLA

Weiner, Adam B., et al. “Survival Following Upfront Chemotherapy for Treatment-Naïve Metastatic Prostate Cancer: A Real-World Retrospective Cohort Study.” Prostate Cancer and Prostatic Diseases, vol. 24, no. 1, Mar. 2021, pp. 261–67. EBSCOhost, https://doi.org/10.1038/s41391-020-00278-0.

APA

Weiner, A. B., Ko, O. S., Li, E. V., Vo, A. X., Desai, A. S., Breen, K. J., Nadler, R. B., & Morgans, A. K. (2021). Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study. Prostate Cancer and Prostatic Diseases, 24(1), 261–267. https://doi.org/10.1038/s41391-020-00278-0

Chicago

Weiner, Adam B, Oliver S Ko, Eric V Li, Amanda X Vo, Anuj S Desai, Kieran J Breen, Robert B Nadler, and Alicia K Morgans. 2021. “Survival Following Upfront Chemotherapy for Treatment-Naïve Metastatic Prostate Cancer: A Real-World Retrospective Cohort Study.” Prostate Cancer and Prostatic Diseases 24 (1): 261–67. doi:10.1038/s41391-020-00278-0.